Torrent Pharmaceuticals (TORNTPHARM) Share Price
NSE · Healthcare · Drug Manufacturers - Specialty & Generic · ISIN INE685A01028
Key metrics
- Market Cap
- ₹1.77 L Cr
- P/E Ratio
- 74.39
- EPS
- 62.6
- Book Value
- 519.58
- P/B Ratio
- 8.89
- ROE
- 12.3%
- ROCE
- 10.55%
- Debt / Equity
- 0.85
- Net Margin
- 15.73%
- Revenue Growth
- 21.52%
- Profit Growth
- 13.19%
- Dividend Yield
- 0.82%
- 52W High
- ₹5,250.00
- 52W Low
- ₹3,480.60
- Market Cap Band
- large cap
- Face Value
- 5
Ratios computed from the annual results period ending 2026-03-31.
About Torrent Pharmaceuticals Limited
Torrent Pharmaceuticals Limited engages in the research, development, manufacturing, marketing, and distribution of branded and generic pharmaceutical formulations in India, the United States, Brazil, Germany, Malta, and internationally. The company offers products in various therapeutic areas, including anti-diabetic, anti-microbial, cardiovascular, CNS, urology, gynecology, oncology, gastro-intestinal, nephrology, neuro-psychiatric, dermatology, pulmonology, pediatric treatments, nutritional, pain management, anti-infective, and miscellaneous, as well as vitamins, minerals, and nutrients. It also provides contract manufacturing services. The company offers its products under Tedibar, Shelcal, Unienzyme, ProZuca, and Ahaglow brands. The company was formerly known as Trinity Laboratories and changed its name to Torrent Pharmaceuticals Limited in 1971. The company was founded in 1959 and is based in Ahmedabad, India. Torrent Pharmaceuticals Limited is a subsidiary of Torrent Investments Private Limited.
- Headquarters
- Ahmedabad, India
- Employees
- 18,258
- Promoter Holding
- 63.18%
Torrent Pharmaceuticals and the Drug Manufacturers - Specialty & Generic industry
Torrent Pharmaceuticals is one of 153 listed companies in the Drug Manufacturers - Specialty & Generic industry. At a P/E of 74.4, it trades above the industry median of 30.9.
All Drug Manufacturers - Specialty & Generic stocks →Healthcare sector stocks →
Related companies
- Sun Pharmaceutical IndustriesSUNPHARMA · ₹1,760.00₹4.22 L Cr
- Divi's LaboratoriesDIVISLAB · ₹9,340.00₹2.48 L Cr
- Zydus LifesciencesZYDUSLIFE · ₹1,117.50₹1.11 L Cr
- Laurus LabsLAURUSLABS · ₹2,036.60₹1.10 L Cr
- CiplaCIPLA · ₹1,301.00₹1.05 L Cr
- Dr. Reddy's LaboratoriesDRREDDY · ₹1,197.00₹99,709 Cr
- Mankind PharmaMANKIND · ₹2,368.50₹97,830 Cr
- Aurobindo PharmaAUROPHARMA · ₹1,693.00₹97,411 Cr
Torrent Pharmaceuticals: key questions
What does Torrent Pharmaceuticals do?
Torrent Pharmaceuticals Limited engages in the research, development, manufacturing, marketing, and distribution of branded and generic pharmaceutical formulations in India, the United States, Brazil, Germany, Malta, and internationally.
What is the share price of Torrent Pharmaceuticals?
Torrent Pharmaceuticals (TORNTPHARM) last traded at ₹4,656.90 on the NSE, unchanged on the day. Over the past 52 weeks it has traded between ₹3,480.60 and ₹5,250.00. The current price is 11.3% below its 52-week high.
What is the market cap of Torrent Pharmaceuticals?
Torrent Pharmaceuticals has a market capitalisation of ₹1.77 L Cr, which makes it a large-cap company. It is the 3rd largest of 153 listed companies in the Drug Manufacturers - Specialty & Generic industry by market capitalisation.
What is the P/E ratio of Torrent Pharmaceuticals?
Torrent Pharmaceuticals trades at a price-to-earnings (P/E) ratio of 74.4. The median P/E across profitable companies in the Drug Manufacturers - Specialty & Generic industry is 30.9.
What are Torrent Pharmaceuticals's ROE and ROCE?
For the financial year ended March 2026, Torrent Pharmaceuticals reported a return on equity (ROE) of 12.3%, a return on capital employed (ROCE) of 10.6% and a net profit margin of 15.7%.
How fast is Torrent Pharmaceuticals growing?
In the financial year ended March 2026, Torrent Pharmaceuticals's revenue grew 21.5% and net profit grew 13.2% compared with the previous year.
Does Torrent Pharmaceuticals have debt?
Torrent Pharmaceuticals has a debt-to-equity ratio of 0.85, meaning borrowings are about 85% of shareholders' equity.
Does Torrent Pharmaceuticals pay a dividend?
Torrent Pharmaceuticals has a dividend yield of 0.82% at the current share price.
What is the promoter holding in Torrent Pharmaceuticals?
Promoters hold 63.2% of Torrent Pharmaceuticals. Institutional investors hold 19.5%.
Which companies are similar to Torrent Pharmaceuticals?
Listed companies close to Torrent Pharmaceuticals in size within the Drug Manufacturers - Specialty & Generic industry include Sun Pharmaceutical Industries, Divi's Laboratories, Zydus Lifesciences, Laurus Labs, Cipla and Dr. Reddy's Laboratories.
Figures are for information only and are not investment advice.
The full Torrent Pharmaceuticals analysis
Create a free account to open the complete TORNTPHARM deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.